Ustar, established in 2005, is committed to the research, development, manufacturing and sales of innovative point-of-care molecular diagnostic technology and products. We have established a technical platform with completely independent IP rights, and applied for over 90 international patents, including 45 authorized patents. Ustar’s POCT kits integrate nucleic acid extraction, purification, amplification, and testing in an enclosed cartridge, enabling fast, accurate, simple, and safe tests for sexually transmitted infections, respiratory infections, blood-borne diseases, livestock and pet health, drug resistance, genotyping and other pipelines. By far, Ustar's products have been certified or authorized by NMPA, CE, ANVISA, TGA, and HSA, and served nearly 3,000 medical institutions in over 70 countries.